We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIG
3351
DELISTED
Fortress Investment Group Llc
FIG
$3K ﹤0.01%
636
-405
-39% -$2.06K
PN
3352
DELISTED
Patriot National, Inc.
PN
$3K ﹤0.01%
676
-240
-26% -$1.58K
WAYN
3353
DELISTED
Wayne Savings Bancshares Inc
WAYN
$3K ﹤0.01%
207
-347
-63% -$5.19K
CNXR
3354
DELISTED
Connecture, Inc.
CNXR
$3K ﹤0.01%
1,936
+367
+23% +$679
LDR
3355
DELISTED
Landauer Inc
LDR
$3K ﹤0.01%
+56
New +$2.64K
ATW
3356
DELISTED
Atwood Oceanics
ATW
$3K ﹤0.01%
200
-2,938
-94% -$28.9K
NVET
3357
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$3K ﹤0.01%
800
+113
+16% +$466
IPN
3358
DELISTED
SPDR S&P International Industrial Sector
IPN
$3K ﹤0.01%
+101
New +$3K
LMIA
3359
DELISTED
LMI Aerospace Inc
LMIA
$3K ﹤0.01%
330
+233
+240% +$1.86K
VAL
3360
DELISTED
Valspar
VAL
$3K ﹤0.01%
28
-3,036
-99% -$313K
CDOR
3361
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$3K ﹤0.01%
257
+142
+123% +$1.68K
IMN
3362
DELISTED
Imation
IMN
$3K ﹤0.01%
4,125
-27,608
-87% -$20.7K
OBAS
3363
DELISTED
Optibase Ltd
OBAS
$3K ﹤0.01%
+360
New +$2.97K
NID
3364
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
$3K ﹤0.01%
+272
New +$3.56K
REV
3365
DELISTED
Revlon, Inc.
REV
$3K ﹤0.01%
+100
New +$3.12K
IIJI
3366
DELISTED
Internet Initiative Japan Inc
IIJI
$3K ﹤0.01%
400
+34
+9% +$271
AST
3367
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$3K ﹤0.01%
+600
New +$2.48K
MSFG
3368
DELISTED
MainSource Financial Group Inc
MSFG
$3K ﹤0.01%
+82
New +$2.36K
AMFW
3369
DELISTED
AMEC Foster Wheeler plc
AMFW
$3K ﹤0.01%
445
-2,130
-83% -$12.8K
DSCI
3370
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$3K ﹤0.01%
524
-317
-38% -$1.49K
PXMC
3371
DELISTED
POWERSHARES FUNDAMENTAL PURE MID CORE PORTFOLIO
PXMC
$3K ﹤0.01%
+80
New +$3K
AEG icon
3372
Aegon
AEG
$14.1B
$2K ﹤0.01%
390
+299
+329% +$1.11K
AFMD
3373
DELISTED
Affimed
AFMD
$2K ﹤0.01%
+84
New +$1.81K
ALLT icon
3374
Allot
ALLT
$383M
$2K ﹤0.01%
+327
New +$1.64K
ALTO icon
3375
Alto Ingredients
ALTO
$340M
$2K ﹤0.01%
+208
New +$1.67K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.